DCGI approves AstraZeneca’s Lynparza for adjuvant treatment of patients with high-risk early breast cancer Read more
Bharat Biotech completes clinical development for phase-III trials and booster doses for BBV154 intra-nasal COVID vaccine Read more
AstraZeneca’s Savannah phase-II trial shows 49 per cent objective response in lung cancer patients Read more
Pfizer to discontinue development programme for PF-07265803 for LMNA-related dilated cardiomyopathy Read more